Background/Aims: We aimed to electrophysiologically evaluate the autonomic function in acromegalic patients using sympathetic skin response (SSR) as a reflection of the sympathetic sudomotor activity and RR interval variation (RRIV) as an indicator of the cardiovagal autonomic function. Methods: The study group consisted of 18 male acromegalics, and the control group was composed of 18 age- and sex-matched healthy subjects. Participants underwent SSR and RRIV tests. Beginning latencies and amplitudes of the median and tibial SSRs were compared among the groups. The RRIV values recorded at rest and during hyperventilation were compared among the patients and controls. Results: Latencies of SSRs recorded from the palms (median) and soles (tibial) of acromegalics were significantly longer than in healthy subjects (p = 0.004, p < 0.001). The amplitude of SSR recorded from the sole (tibial) was significantly decreased (p = 0.028). The RRIVs obtained from acromegalics at rest and during hyperventilation were significantly decreased compared with those of controls (p < 0.001). The RRIVs obtained from controls prolonged significantly during hyperventilation (p < 0.001); however, in the acromegaly group, hyperventilation did not cause a significant change in RRIV (p = 0.983). Conclusions: The present study suggests that an autonomic dysfunction exists in patients with acromegaly. Dysautonomia in acromegalics may be documented by means of SSR and RRIV.

Keywords:
Autonomic dysfunction, Sympathetic skin response, RR interval variation, Acromegaly
1.
Colao A, Merola B, Ferone D, Lombardi G: Acromegaly. J Clin Endocrinol Metab 1997;82:2777–2781.
2.
Taslipinar A, Bolu E, Kebapcilar L, Sahin M, Uckaya G, Kutlu M: Insulin-like growth factor-1 is essential to the increased mortality caused by excess growth hormone: a case of thyroid cancer and non-Hodgkin’s lymphoma in a patient with pituitary acromegaly. Med Oncol 2009;26:62–66.
3.
Leon-Carrion J, Martin-Rodriguez JF, Madrazo-Atutxa A, Soto-Moreno A, Venegas-Moreno E, Torres-Vela E, Benito-López P, Gálvez MA, Tinahones FJ, Leal-Cerro A: Evidence of cognitive and neurophysiological impairment in patients with untreated naive acromegaly. J Clin Endocrinol Metab 2010;95:4367–4379.
4.
Tagliafico A, Resmini E, Nizzo R, Bianchi F, Minuto F, Ferone D, Martinoli C: Ultrasound measurement of median and ulnar nerve cross-sectional area in acromegaly. J Clin Endocrinol Metab 2008;93:905–909.
5.
Del Rio G, Velardo A, Mascadri C, Zalteri G, Papi G, Menozzi R, Giustina A: Baseline and stimulated catecholamine secretion in normotensive patients with active acromegaly: acute effects of continuous octreotide infusion. Eur J Endocrinol 2000;142:179–186.
6.
Rosenberg I, Manchon P, Sabatier C, Hazard J, Lhoste F: Effects of thyrotrophin-releasing hormone on plasma catecholamine levels in acromegaly. Acta Endocrinol (Copenh) 1985;109:19–24.
7.
Cryer P: Plasma norepinephrine and epinephrine in acromegaly. J Clin Endocrinol Metab 1975;41:542–545.
8.
Van Loon GR: Abnormal plasma catecholamine response in acromegalics. J Clin Endocrinol Metab 1979;48:784–789.
9.
Capaldo B, Lembo G, Rendina V, Guida R, Marzullo P, Colao A, Lombardi G, Saccà L: Muscle sympathetic nerve activity in patients with acromegaly. J Clin Endocrinol Metab 2000;85:3203–3207.
10.
Resmini E, Casu M, Patrone V, Murialdo G, Bianchi F, Giusti M, Ferone D, Minuto F: Sympathovagal imbalance in acromegalic patients. J Clin Endocrinol Metab 2006;91:115–120.
11.
Muslumanoglu L, Akyuz G, Aki S, Karsidag S, Us O: Evaluation of autonomic nervous system functions in poststroke patients. Am J Phys Med Rehabil 2002;81:721–725.
12.
Clinchot DM, Lorch F: Sympathetic skin response in patients with reflex sympathetic dystrophy. Am J Phys Med Rehabil 1996;75:252–256.
13.
Neuman L, Berzak A, Bushkila D: Measuring health status in Israeli patients with fibromyalgia syndrome and widespread pain and healthy individuals: utility of the short form 36 item health survey (SF-36). Semin Arthritis Rheum 2000;29:400–408.
14.
Raj SR, Brouillard D, Simpson CS, Hopman WM, Abdollah H: Dysautonomia among patients with fibromyalgia: a noninvasive assessment. J Rheumatol 2000;27:2660–2665.
15.
Vetrugno R, Liguori R, Cortelli P, Montagna P: Sympathetic skin response: basic mechanisms and clinical applications. Clin Auton Res 2003;13:256–270.
16.
Sneppen SB, Main KM, Juul A, Pedersen LM, Kristensen LO, Skakkebaek NE, Feldt-Rasmussen U: Sweat secretion rates in growth hormone disorders. Clin Endocrinol (Oxf) 2000;53:601–608.
17.
Arunodaya GR, Taly AB: Sympathetic skin response: a decade later. J Neurol Sci 1995;129:81–89.
18.
Vita G, Princi P, Messina C: Multivariate analysis of cardiovascular reflexes applied to the diagnosis of autonomic neuropathy. J Neurol 1991;238:251–255.
19.
Vanoli E, Schwartz PJ: Sympathetic-parasympathetic interaction and sudden death. Basic Res Cardiol 1990;85(suppl 1):305–321.
20.
Saccà L, Cittadini A, Fazio S: Growth hormone and the heart. Endocr Rev 1994;15:555–573.
21.
Thuesen L, Christiansen SE, Weeke J, Orskov H, Henningsen P: A hyperkinetic heart in uncomplicated active acromegaly: explanation of hypertension in acromegalic patients? Acta Med Scand 1988;223:337–343.
22.
Andersson IJ, Barlind A, Nyström HC, Olsson B, Skøtt O, Mobini R, Johansson M, Bergström G: Reduced sympathetic responsiveness as well as plasma and tissue noradrenaline concentration in growth hormone transgenic mice. Acta Physiol Scand 2004;182:369–378.
© 2011 S. Karger AG, Basel
2011
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.